INTRODUCTION: Salivary gland tumors (SGTs) are rare and their annual incidence is <1/100,000 inhabitants, without noticeable geographical gap, and they represent <5% of head and neck tumors.1. Material and method–Salivary gland tumors diagnosed in the department of pathology gmc Aurangabad, maharashtra during 3 years duration between Jan 2016 to Dec 2018 were included in this study which forms 2 years retrospective and 1 years prospective study. Result– Out of 40 cases, 6 cases were diagnosed as a non–neoplastic 26 were diagnosed as benign and 8 as malignant tumours of Salivary gland constituting 15 % , 65 % and 20 % respectively. Most common benign tumour was pleomorphic adenoma and most common malignant tumour was adenoid cystic carcinoma. Coclusion– Histomorphology is the gold standard in the diagnosis of salivary gland tumours. Among all salivary glands tumours. . very few studies are available on head and neck tumours hence larger studies needed for discriminate and influencing factors.